Diabetes 文獻一篇

bjouxz

Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15.
( F( r& `9 _! y! R! UThe Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.- V! d8 {: O/ M' e/ @5 P6 e
Thazhath SS1, Marathe CS1, Wu T1, Chang J1, Khoo J1, Kuo P2, Checklin HL1, Bound MJ1, Rigda RS1, Crouch B3, Jones KL1, Horowitz M1, Rayner CK4, q3 n& z  R3 S% x
. B4 m9 a# {+ W2 X8 I; E- ~
Link: http://diabetes.diabetesjournals.org/content/65/1/269.long ( k4 m0 q! i- p6 s
: u8 F% I' }2 h8 e& a$ Q5 V. F
Thanks so much!

farui

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial$ ^! I; T. |/ j4 d7 R